Forecast to 2022
Page 1
changed to multi-material printers, which are chiefly used for prototyping. Currently, 3D
printing services in healthcare sector is used mainly for preparation of anatomical models,
medical equipments, prosthetic parts and tailor-made sensors etc for hospitals with
comprehensive quality.
At present, bioprinting is still in its formative years where demand for tissue engineering and
transplanting organs has raised in the market to meet the unmet need. Recently, in March
2016, life of nine-month old baby with congenital heart defect was saved by Chinese doctors
by performing open heart surgery utilizing Materialises Mimics software to convert MRI scan
to 3D printed heart. These kind of advanced technologies has not only shown path for tissue
engineering segment but also has taken a great step towards development of regenerative
medicine and cell culture where scientists have developed 3D printed embryonic stem cell
blocks for tissue regeneration and medical testing purpose which is a breakthrough event in
the industry. In February 2016, Cell Applications and Cyfuse Biomedical introduced scaffoldfree Kenzan method where array of needles are used for development of manipulatable
vascular tissues for heart, liver, skin, pancreas, lung & trachea and cartilage which is settingup a trend in the industry. As estimated by IQ4I Research, the global 3D printing healthcare
market is expected to reach $2,841.2 million by 2022.
Eventually, rise in 3D printing technology has rolled its focus on pharmaceutical industry
where personalized medicine with appropriate dosage, size, color and delivery mode is
adopted for improved patient-care. For instance, in August 2015 Aprecia pharmaceuticals
developed Spritam, an anti-epileptic drug for epileptic seizures. Since, populace are gearing
up to adapt novel technologies for betterment of healthy lives, factors such as high demand
for customized implants, high investment in R&D and usage of CAD/CAM technology are
driving the market, whereas, high cost of printers and limited type of material availability are
the factors hindering the market growth. Reimbursement is still a challenge, as the
technology is expensive.
Patents are explored for both process and technologies from the year 2011-2016 since,
continuous research and innovations are on-going from different companies for advanced
product offerings. Filing of patents exhibited significant impact on the growth of companys
product portfolio to maintain dominant position in the industry. Some of the major companies
included in 3D printing healthcare market are 3D systems, Arcam AB, EnvisionTEC, EOS,
ExOne, Materialise N.V., Optomec, Organovo, Reinshaw, Nano3D biosciences, SLM
solutions and Stratasys. At present, extensive choice of viable 3D printers for various
IQ4I Research & Consultancy Pvt. Ltd.
Page 2
industrial applications are available where 3D Systems and Stratasys plays a major role with
high market capitalization.
Reasons for buying this report:
Identification of the major market trends and factors driving or inhibiting the growth of
the 3d printing medical/healthcare global market.
Patent trends, supply chain analysis and recent trends of the 3d printing
medical/healthcare market.
Established and Emerging players (65 companies) and their product offerings.
Page 3
FIGURE 1
3D PRINTING MEDICAL/HEALTHCARE GLOBAL MARKET SEGMENTATION
Category
Process
Application
End-user
Region
Products
PP
Deposition
Fusion
Jetting
Implant
Hospitals
North
America
Services
Stereolitho
graphy
FDM
DMLS
Multijet/
Polyjet
Surgical
Guides
Pharma &
Biotech
Europe
Materials
DLP
Extrusion
Bioprinting
SLS
Binder
Jetting
Tissue
Engineering
Academic
Institutes
AsiaPacific
EBM
Ink Jet
Bioprinting
Surgical
Instruments
Others
Row
2 PP
SLM
Pharmaceu
tical
Laser
Bioprinting
Page 4